Home
All|
Business |
Technology |
Environment |
Health & Fitness |
Lifestyle |
Entertainment |
Travel |
Politics & Society |
Sports |
RSSA new, oral type 2 diabetes medicine, Galvus has showed fewer side effects than present treatments. It stimulates pancreas to regulate blood sugar levels smoothly. Weight management is the key factor for the people to deal with diabetes.
Galvus has...
Related Stories
Most Recent
Most Popular
Most Commented
1
Star It 
(0)
AP, Trenton
Drugmaker Merck & Co. has asked federal regulators to approve use in males for its vaccine against the human papillomavirus, which causes cervical and other...
made popular Jan 6 2009
AP, Trenton
Schering-Plough Corp. says sales of the cholesterol drugs it markets with partner Merck & Co. have started dropping again.
made popular Dec 18 2008
AP, Whitehouse Station
Drugmaker Merck & Co. said Tuesday it is taking steps to become a leader in generic biotechnology drugs and sales in emerging markets, diversifying its research...
made popular Dec 9 2008
AP, Whitehouse Station
Drugmaker Merck & Co. tried to reassure investors Tuesday that its latest restructuring strategy will put the company back on a growth track as it moves into new...
made popular Dec 9 2008
AP, New York
Merck says its profit will fall in 2009 due to restructuring costs, generic competition and slower sales of key products.
made popular Dec 4 2008
AP, Trenton
Lawsuits against Merck & Co. and partner Schering-Plough Corp. related to their marketing of cholesterol drug Vytorin are piling up, and the U.S. Department of...
made popular Nov 4 2008
AP, Trenton
Drugmaker Merck & Co. said Wednesday it will slash 7,200 jobs as part of a new restructuring program that comes as its third-quarter profit plunged 28 percent, due...
made popular Oct 22 2008
AP, Whitehouse Station
Merck says its quarterly profit dropped 28 percent, and it’s starting another restructuring program that will slash more jobs.
made popular Oct 22 2008
AP, Trenton
Merck & Co. is expanding an already-large study of an experimental cholesterol drug _ rejected this spring by U.S. regulators _ to get results sooner so it can...
made popular Oct 17 2008
AP, Trenton
A doubled risk of heart attack, stroke and death persisted at least a year after people stopped taking withdrawn painkiller Vioxx, according to an analysis of long-term...
made popular Oct 13 2008
AP, Trenton
Florida has joined eight other states in suing drugmaker Merck & Co. over what the state alleges was deceptive marketing of its former prescription painkiller...
made popular Oct 1 2008
AP, Trenton
A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company...
made popular Sep 16 2008
There is good news for those AIDS patients who have stopped responding to available drugs in the name of Isentress [also called raltegravir], a new drug developed by...
made popular Sep 9 2008
AP, Trenton
Partial payments for people claiming withdrawn painkiller Vioxx caused heart attacks will go out starting Aug. 28 under the $4.85 billion settlement between drugmaker...
made popular Aug 20 2008
AP, Trenton
A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach...
made popular Aug 18 2008
AP, Trenton
In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn’t prevent worsening of...
made popular Jul 21 2008
AP, New York
Wall Street fluctuated Monday as investors worried about earnings at drug makers Merck & Co. and Schering-Plough Corp., and oil prices moved higher.Both...
made popular Jul 21 2008
AP, New York
Wall Street turned lower Monday as investors worried about earnings at drug makers’ Merck & Co. and Schering-Plough Corp., and oil prices moved higher.Both...
made popular Jul 21 2008
AP, New York
Drug makers Schering-Plough Corp. and Merck & Co. delayed their second-quarter results until after the closing bell Monday so investigators can present data from a...
made popular Jul 21 2008
AP, Trenton
Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion...
made popular Jul 17 2008
All Stories
Most Recent
Most Popular
Most Commented
The U.S. Food and Drug Administration had accepted the oral therapy Galvus of Novartis for people with Type 2 diabetes for standard review, the Swiss drug firm said on...
made popular Mar 31 2006
Related Tags
Bank Leu blood sugar FDA Health & Fitness Merck Novartis Oral Diabetes Therapy type 2 diabetes U.S. Food and Drug Administratio Vildagliptin
